We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Hepatic arterial infusion of floxuridine, leucovorin, doxorubicin, and cisplatin for hepatocellular carcinoma: effects of hepatitis B and C viral infection on drug toxicity and patient survival.
- Authors
Patt, Y Z; Charnsangavej, C; Yoffe, B; Smith, R; Lawrence, D; Chuang, V; Carrasco, H; Roh, M; Chase, J; Fischer, H
- Abstract
To conduct a pilot trial of hepatic arterial infusion (HAI) of floxuridine (FUDR), leucovorin, Adriamycin (doxorubicin; Adria Laboratories, Columbus, OH), and cisplatin (FLAP) in nonresectable hepatocellular cancer (HCC) confined to the liver and assess the effects of hepatitis B (HBV) and hepatitis C (HCV) viral markers on toxicity, response to treatment, and patient survival.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Vol 12, Issue 6, p1204
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.1994.12.6.1204